ANDA 62392, held by Watson Labs. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62392 (Doxycycline Hyclate), held by Watson Labs, was first approved by FDA on Mar 31, 1983, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 31, 1983 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 50MG BASE · tablet;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 100MG BASE · tablet;oral | Doxycycline Hyclate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters